Correlation Between Revolution Medicines and Mersana Therapeutics
Can any of the company-specific risk be diversified away by investing in both Revolution Medicines and Mersana Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines and Mersana Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revolution Medicines and Mersana Therapeutics, you can compare the effects of market volatilities on Revolution Medicines and Mersana Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines with a short position of Mersana Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines and Mersana Therapeutics.
Diversification Opportunities for Revolution Medicines and Mersana Therapeutics
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Revolution and Mersana is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and Mersana Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mersana Therapeutics and Revolution Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines are associated (or correlated) with Mersana Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mersana Therapeutics has no effect on the direction of Revolution Medicines i.e., Revolution Medicines and Mersana Therapeutics go up and down completely randomly.
Pair Corralation between Revolution Medicines and Mersana Therapeutics
Given the investment horizon of 90 days Revolution Medicines is expected to generate 1.67 times less return on investment than Mersana Therapeutics. But when comparing it to its historical volatility, Revolution Medicines is 2.63 times less risky than Mersana Therapeutics. It trades about 0.22 of its potential returns per unit of risk. Mersana Therapeutics is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest 145.00 in Mersana Therapeutics on September 2, 2024 and sell it today you would earn a total of 83.00 from holding Mersana Therapeutics or generate 57.24% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Revolution Medicines vs. Mersana Therapeutics
Performance |
Timeline |
Revolution Medicines |
Mersana Therapeutics |
Revolution Medicines and Mersana Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Revolution Medicines and Mersana Therapeutics
The main advantage of trading using opposite Revolution Medicines and Mersana Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines position performs unexpectedly, Mersana Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mersana Therapeutics will offset losses from the drop in Mersana Therapeutics' long position.Revolution Medicines vs. Blueprint Medicines Corp | Revolution Medicines vs. Sana Biotechnology | Revolution Medicines vs. Kymera Therapeutics | Revolution Medicines vs. Monte Rosa Therapeutics |
Mersana Therapeutics vs. Terns Pharmaceuticals | Mersana Therapeutics vs. Amylyx Pharmaceuticals | Mersana Therapeutics vs. Acumen Pharmaceuticals | Mersana Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |